To clarify how anti-adipogenic factors act on preadipocytes to inhibit their differentiation, we compared preadipocyte signaling responses generated by platelet-derived growth factor (PDGF; anti-adipogenic) versus insulin (pro-adipogenic). PDGF, but not insulin, stimulated the phosphorylation of inhibitor of kB kinase b (IKKb) in a time-dependent manner. This PDGF-dependent phosphorylation event was inhibited by 60% (P!0 . 05) when the cells were pretreated with wortmannin, indicating a requirement for the phosphatidylinositol (PI) 3-kinase/AKT pathway. IKKb phosphorylation by PDGF was neither accompanied by IkBa degradation nor NF-kB activation. PDGF inhibited human adipocyte differentiation, assessed by triacylglycerol accumulation (75% reduction; P!0 . 01) and by fatty acid synthase protein expression (60% reduction; P!0 . 05); these responses were no longer apparent in the presence of sc-514, a selective inhibitor of IKKb. Our data describe a novel PDGF response in human preadipocytes that involves the pro-inflammatory kinase IKKb and demonstrate that it is required for the inhibition of adipogenesis.
Introduction
Preadipocytes are mesenchymal fibroblast-like cells within the stromal compartment of adipose tissue that are committed to the adipocyte lineage (Scadden 2007) . Healthy adipose tissue growth and functionality are maintained when differentiation of preadipocytes into adipocytes is coordinated with lipid storage within mature adipocytes.
Obesity, commonly defined as an excess of adipose tissue mass, can also be characterized by the functional status of adipocytes. In particular, insulin resistance and inflammation are features of hypertrophied adipocytes (Schenk et al. 2008) . Their prominence in adipose tissue may be a compensatory response for reduced adipogenic capacity when energy balance is chronically positive (Danforth 2000 , Heilbronn et al. 2004 , Dubois et al. 2006 . Preventing the decrease in adipocyte differentiation is therefore a potential therapeutic target to restore insulin sensitivity, and learning more about signaling pathways activated by anti-adipogenic factors may be informative.
Platelet-derived growth factor (PDGF) is a negative regulator of adipogenesis (Hauner et al. 1995 , Krieger-Brauer & Kather 1995 , Artemenko et al. 2005 . PDGF receptor (PDGFR) mRNA and protein levels fall during 3T3-L1 adipocyte differentiation (Vaziri & Faller 1996 , Summers et al. 1999 , Whiteman et al. 2003 , and a correlation between PDGFR expression and adipocyte size has also been observed (Bluher et al. 2004) . Recent reports have further highlighted the physiological relevance of PDGF in adipose tissue inflammation (Nishimura et al. 2008 , Pang et al. 2008 .
To identify anti-adipogenic preadipocyte signaling networks activated by PDGF, we compared preadipocyte responses elicited by PDGF versus insulin, a pro-adipogenic factor (Gagnon et al. 1999 ). Our data demonstrate that PDGF, but not insulin, activates the inhibitor of kB kinase b (IKKb) in human preadipocytes. Inhibition of this event with an IKKb inhibitor curtails the anti-adipogenic action of PDGF, highlighting its importance as a key PDGF signaling response in these cells.
Materials and Methods
Culture of 3T3-L1 preadipocytes and screening of activated kinases 3T3-L1 preadipocytes were grown to confluence in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% calf serum, 100 U/ml penicillin, and 0 . 1 mg/ml streptomycin (all from Invitrogen). Cells were placed in serum-reduced condition overnight prior to 5-min stimulation with 1 mM insulin or 10 ng/ml PDGF-BB (Calbiochem, San Diego, CA, USA). Cellular lysates were prepared by solubilizing proteins in Laemmli buffer (Laemmli 1970) supplemented with 1 mM sodium orthovanadate, 5 mM sodium pyrophosphate, 50 mM sodium fluoride (NaF), and 5 mM EGTA. Samples were sent to Kinexus for analysis of phosphorylated kinases with a Kinetworks phosphosite screen (KCPS-1.0). Alternatively, cellular lysates were processed for immunoblot analysis, as described below.
Isolation and culture of human preadipocytes
Subcutaneous adipose tissue was obtained from 19 patients (15 women and 4 men) undergoing elective abdominal surgery (approved by The Ottawa Hospital Research Ethics Board). Mean age was 51G12 year, and mean body mass index (BMI) was 30G6 kg/m 2 (GS.D.; range from 22 to 48 kg/m 2 ). We did not detect any obvious effects on IKKbrelated cellular responses associated with this variation in BMI. Preadipocytes were isolated as previously described (Artemenko et al. 2005) . Briefly, tissue was separated from connective tissue and capillaries by dissection, then digested with collagenase CLS type I (600 U/g of tissue; Worthington, Lakewood, NJ, USA). The digested tissue was subjected to progressive size filtration and centrifugation, followed by incubation in erythrocyte lysis buffer. Preadipocytes were seeded at a density of 3!10 4 cells/cm 2 and grown to confluence in DMEM supplemented with 10% fetal bovine serum (Invitrogen), 100 U/ml penicillin, 0 . 1 mg/ml streptomycin, and 50 U/ml nystatin (Calbiochem). Confluent cultures were used either for stimulation or differentiation studies, as described below.
Stimulation of human preadipocytes
Prior to stimulation, confluent preadipocytes were maintained in DMEM supplemented with 0 . 5% calf serum and antibiotics for 16-20 h. Cells were placed in Krebs-Ringer-HEPES (KRH) buffer (Gagnon et al. 1999) , and stimulated at 37 8C with 1 mM insulin, 5-20 ng/ml PDGF-BB or vehicle (2 mg/ml BSA in KRH), for up to 30 min, as indicated. For some experiments, cells were pretreated for 1 h with 100 mM sc-514 (Calbiochem), for 15 min with 100 nM wortmannin (Kamiya Biochemical Company, Seattle, WA, USA), or vehicle (0 . 1% DMSO) prior to stimulation, as indicated.
Proteins were solubilized in Laemmli buffer (Laemmli 1970) supplemented with 1 mM sodium orthovanadate, 5 mM sodium pyrophosphate, 50 mM NaF, and 5 mM EGTA.
Differentiation of human preadipocytes
Confluent human preadipocytes were pretreated for 15 min with 100 mM sc-514 (Calbiochem) or 0 . 1% DMSO prior to induction of differentiation. Differentiation was induced as previously described (Artemenko et al. 2005) by supplementing the medium with 5 mg/ml insulin, 100 mM indomethacin, 0 . 5 mM dexamethasone, and 0 . 25 mM isobutylmethylxanthine in the presence or absence of 10 ng/ml PDGF-BB, and either 100 mM sc-514 or 0 . 1% DMSO. After 12 to 15 days, cultures were photographed with a Nikon Coolpix 995 digital camera mounted on a Nikon Eclipse TS100 microscope. Cells were washed, and triacylglycerol (TG) was extracted and quantified spectrophotometrically (Gagnon et al. 1999) . Proteins were solubilized in Laemmli buffer (Laemmli 1970) and used in immunoblot analysis.
Immunoblot analysis
Equal amounts of protein (5-25 mg depending on the experiment) were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. Non-specific binding sites were blocked and membranes were incubated with antibodies specific for actin (0 . 4 mg/ml; Santa Cruz Biotech., Santa Cruz, CA, USA), AKT (clone C-20; 2 mg/ml; Santa Cruz Biotech.), fatty acid synthase (FAS; 1 . 0 mg/ml; BD Biosciences, Mississauga, ON, Canada), inhibitor of kBa (IkBa; 1:1000), IKKb (1:500), phospho-AKT Ser473 (pAKT; 1:1000), or phospho-IKK (pIKK; 1:500), all from Cell Signaling (Danvers, MA, USA).
Preparation of nuclear extracts and NF-kB DNA-binding assay
Human abdominal s.c. preadipocytes were placed in DMEM supplemented with 1% calf serum and antibiotics. Cells were pretreated with either 100 mM sc-514 or 0 . 1% DMSO for 1 h, then treated with or without 10 ng/ml PDGF for 30 min. Cells were washed twice with ice-cold PBS/phosphatase inhibitor buffer, then placed in 20 mM Hepes, pH 7 . 5, 5 mM NaF, 10 mM Na 2 MoO 4 , and 0 . 1 mM EDTA, and allowed to swell. Nonidet P-40 was added to a final concentration of 0 . 5%, then the homogenates were centrifuged at 14 000 g for 1 min at 4 8C. Nuclear pellets were then processed for NF-kB DNA-binding activity using the TransAM NF-kB kit (Active Motif, Carlsbad, CA, USA), according to the manufacturer's instructions. A nuclear fraction prepared from activated Jurkat cells, provided with the kit, was used as a positive control for the assay.
Statistical analyses
ANOVA was performed, followed by the Newman-Keul's test to assess differences between means (Instat, version 3.05; GraphPad, San Diego, CA, USA) P values !0 . 05 were considered significant.
Results
IKKb phosphorylation occurs in response to PDGF, but not insulin, in 3T3-L1 and human preadipocytes
In a search for intracellular targets differentially regulated by insulin and PDGF, 3T3-L1 preadipocytes were stimulated for 5 min with insulin or PDGF. A commercial phosphokinase screen of cellular lysates by Kinexus was conducted. Whereas the phosphorylation of some kinases in response to PDGF versus insulin was similar, the phosphorylation of IKKb was 12 . 4-fold higher in PDGF-versus insulin-treated 3T3-L1 preadipocytes (Fig. 1A) . We confirmed this large differential signaling response in 3T3-L1 preadipocytes, and demonstrated that it also occurred in primary human abdominal s.c. preadipocytes (Fig. 1B) . Treatment with 10 ng/ml PDGF for 5 min increased IKKb phosphorylation by 20-fold (P!0 . 001) and 7 . 6-fold (P!0 . 01), compared with basal, in 3T3-L1 and human preadipocytes respectively. Treatment with 1 mM insulin failed to increase IKKb phosphorylation.
IKKb phosphorylation by PDGF depends on phosphatidylinositol (PI) 3-kinase
To further characterize the regulation of IKKb by PDGF, human preadipocytes were treated with insulin or PDGF for the indicated times. IKKb phosphorylation was transiently stimulated by PDGF, with a 16-fold increase within 5 min of exposure (P!0 . 001), which returned to basal levels within 30 min ( Fig. 2A) . IKKb phosphorylation in response to insulin was not observed at any of the times tested. Maximal IKKb phosphorylation was observed at a dose of 5 ng/ml PDGF (Fig. 2B) . Pretreatment with wortmannin, a specific PI3-kinase inhibitor, significantly reduced PDGF-induced IKKb phosphorylation by 60% (P!0 . 05), implicating the PI3-kinase/AKT pathway in this regulation (Fig. 2C) . Insulin, like PDGF, also stimulated AKT phosphorylation, but did not have a significant effect on IKKb phosphorylation.
PDGF-induced IKKb phosphorylation does not lead to the degradation of IkBa and activation of NF-kB
To investigate downstream signaling events beyond PDGFstimulated IKKb phosphorylation, we assessed the degradation of IkBa and activation of NF-kB, known consequences of IKKb activation. However, the levels of IkBa were unchanged in PDGF-treated human preadipocytes. Consistent with this observation, PDGF failed to activate NF-kB, assessed by DNA binding to an NF-kBspecific response element. 
Sc-514 reverses the anti-adipogenic effect of PDGF on human adipogenesis
We examined the functional role of IKKb with respect to PDGF-mediated inhibition of adipogenesis. Human abdominal s.c. preadipocytes were treated with sc-514, a selective inhibitor of IKKb (Kishore et al. 2003) , for 15 min, followed by induction of differentiation, either in the presence or absence of 10 ng/ml PDGF. As previously reported (Artemenko et al. 2005) , PDGF treatment strongly reduced the morphological changes that characteristically occur during adipocyte differentiation, including the accumulation of lipid droplets (Fig. 3A) . The inhibitory effect of PDGF on lipid droplet accumulation was nullified by sc-514. These morphological effects were quantified by measuring cellular TG content (Fig. 3B) . TG accumulation was reduced by 75%
(P!0 . 01) in response to PDGF, but when sc-514 was present, the inhibition by PDGF was only 28%, and was no longer significant. Consistent with this response, the protein expression of FAS, an adipogenic marker, was reduced by 60% (P!0 . 05) in the presence of PDGF, but with sc-514 present, the inhibition by PDGF was attenuated to 23%, and no longer reached significance (Fig. 3C ). There was no significant effect on either FAS expression or TG accumulation with sc-514 alone.
Discussion
PDGF is a growth factor that is known to be anti-adipogenic (Hauner et al. 1995 , Krieger-Brauer & Kather 1995 , Artemenko et al. 2005 . PDGFR expression is regulated according to the stage of adipocyte differentiation as well as by adipocyte cell size (Vaziri & Faller 1996 , Summers et al. 1999 , Whiteman et al. 2003 , Bluher et al. 2004 . Here, we demonstrate that IKKb is activated by PDGF in human preadipocytes, and that it is required for the inhibition of adipogenesis by PDGF. IKKb was phosphorylated by PDGF, but not by insulin, a pro-adipogenic agent. Only a few other studies have linked the IKKb/NF-kB pathway to PDGF signaling and responses in other cell types. NF-kB participates in the regulation of PDGF-inducible genes and cell transformation in mouse fibroblasts (Olashaw et al. 1992) . In addition, anti-apoptotic and proliferative responses by human skin fibroblasts and rat synoviocytes induced by PDGF depend on IKKb/NF-kB (Romashkova & Makarov 1999) . To our knowledge, this is the first study reporting the regulation of this pro-inflammatory pathway in human adipose cells.
The phosphorylation of IKKb observed in response to PDGF treatment of human preadipocytes was not accompanied by degradation of IkBa or activation of NF-kB. Although infrequent, activation of IKKb, without concomitant NF-kB activation was recently shown to occur with respect to the regulation of interferon-g-dependent genes (Tudhope et al. 2007 ). IKKb has also been reported to directly phosphorylate substrates such as IRS-1 (on serine residue 307/312; rodent/human), as well as FOXO3, and 14-3-3b (Perkins 2007) ; these proteins have been implicated in the regulation of adipose tissue function (Miki et al. 2001 , Hong et al. 2005 , Luo et al. 2008 . Further research will be needed to evaluate the possible roles of each of these candidate proteins with respect to the PDGF-mediated anti-adipogenic effect we have observed here.
The role of the PI3-kinase/AKT pathway in the activation of IKKb has been noted in other cells (Parhar et al. 2007 , Dan et al. 2008 . It has been demonstrated that AKT and IKKb associate in response to PDGF (Romashkova & Makarov 1999) . However, it is unclear why insulin, which also activates AKT in human preadipocytes, does not lead to IKKb phosphorylation. We have previously shown that antiadipogenic PDGF generates both PI(3,4)P2 and PI(3,4,5)P3, while pro-adipogenic insulin leads to accumulation of only PI(3,4,5)P3 in preadipocytes (Sorisky et al. 1996 , Gagnon et al. 1999 . This differential generation of 3-phosphoinositides by these two agonists may alter the activation characteristics of AKT or its cellular compartmentalization, leading to the activation/phosphorylation of distinct arrays of substrates that may differentially modulate the activation of IKKb. It is also possible that other, as yet unidentified, upstream regulatory molecules play a role in PDGF-stimulated IKKb phosphorylation. Previous studies have examined PDGF and preadipocytes to determine which downstream signaling events are involved in its ability to inhibit adipogenesis. Conventional protein kinase C (PKCs) have been implicated in studies investigating the anti-adipogenic effect of PDGF on human preadipocytes (Artemenko et al. 2005) , and conventional PKCs, ERK1/2, and NADPH-dependent H 2 O 2 generation have been reported using 3T3-L1 preadipocytes (Krieger-Brauer & Kather 1995 , Camp & Tafuri 1997 , Artemenko et al. 2005 . At present, the precise relationship between these signaling events in preadipocytes and the activation of the IKKb pathway is unknown, but merits attention.
Our studies with the pharmacological inhibitor sc-514 suggest that IKKb participates in the anti-adipogenic effects of PDGF. Sc-514 has been shown to be a potent inhibitor of IKKb, with ten times more selectivity for IKKb than many other kinases stimulated by PDGF, including ERKs, p38 MAPK, and conventional PKCs (Kishore et al. 2003) . Further studies, such as RNA silencing, would nonetheless complement these findings.
In summary, our data reveal a pro-inflammatory signaling response that is a required element for the anti-adipogenic effect of PDGF on human preadipocytes.
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